Intelect Medical Inc.

The field of neuromodulation, or the introduction of nerve stimulation into the central nervous system, peripheral nervous system, autonomic nervous system, or deep cell nuclei of the brain via an imp

Deep brain stimulation (DBS) devices, on the market for 20 years, have enabled the successful treatment of more than 100,000 patients worldwide with debilitating and increasingly prevalent neurologica

Skin cancer companion Dx earns approval FDA has approved BioMerieux Inc. ’s THxID BRAF kit, a companion diagnostic test that will help determine if a patient’s melanoma cells have BRAF V600E or V

Neuromodulation devices represent one of the largest and fastest growing segments of the worldwide medical device market. These technologies selectively alter or “modulate” the transmission of nerve i